Table 1.

Clinical and laboratory data of the patients at the time of study

Patient Number	Age	Gender	ANCA Titre	Clinical Status	Treatment	Organ Involvement
1	37	M	PR3 60 U	Remission	Nil	R, J
2	69	M	PR3 34 U	Newly Diagnosed	Prednisolone 5 mg/day	R, J
3	56	M	PR3 >100 U	Relapse	Nil	R, J, S, P
4	73	F	PR3 >100 U	Newly Diagnosed	Nil	R, L, E
5	50	M	PR3 33 U	Newly Diagnosed	Nil	L, E, J
6	63	M	MPO >100 U	Newly Diagnosed	Nil	R, L, C, J
7	77	M	MPO 54 U	Newly Diagnosed	Nil	R, L
8	67	M	MPO 38 U	Relapse	Nil	R, L
9	57	M	MPO 47U	Relapse	Nil	R, S, L
10	82	M	MPO >100 U	Newly Diagnosed	Nil	R, J

R = Renal, E = ENT, L = Lung, C = Cardiac, J = Joints, S = Skin, P = Peripheral Neuropathy